Today in Healthcare: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Healthcare.

Press releases published on July 10, 2026

Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Best China Spinal Implants and THR/TKR Manufacturers for Russia’s Orthopedic Surgery Market
China Orthopedic Trauma Implant and External Fixation Manufacturers for Egypt’s Medical Distributor Market
Top China Orthopedic Sports Medicine and Trauma Implant Suppliers for Vietnam’s Growing Healthcare Market
China Orthopedic Power Tool and Surgical Instrument Manufacturers for Thailand’s Orthopedic Market
Reliable China Sternal Fixation System and Spinal Implants Suppliers for Malaysia’s Surgical Device Market
Top China Total Hip/Knee Replacement Suppliers for Mexico’s Joint Reconstruction Market
Dr. Latrece Wright Releases New Book The Uninvited Pebble About a Breast Cancer Scare and Hope
ProcellaRX Adds MH Consulting & Advisory as Strategic Partner in Ascend Ecosystem
AACD's Give Back a Smile Celebrates 27 Years; Christopher Sprout, DDS Joins Colorado Volunteers in Expanding the Program
Elevar Therapeutics Receives FDA Complete Response Letter for Combination of Rivoceranib and Camrelizumab as a First-line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma
TeleDirectMD Adds Major Insurance, Expands to 40+ States, serving 10 of 11 World Cup Venues
AB Science provides an update on its clinical program, suspending some non-priority clinical trials to focus on two clinical programs
AB Science fait le point sur son programme clinique avec l’arrêt de certaines études cliniques non prioritaires en vue de se concentrer sur deux programmes cliniques
Neuro RehabCare Expands Regional Rehabilitation Reach in Des Moines, IA
Cosmos Health Launches Subscription Model
FDA Proposes Rule to Modernize Drug Manufacturing Registration
Microscopy Market to Grow from USD 8.81 Billion in 2025 to USD 11.44 Billion by 2031, at a CAGR of 5.5% – MarketsandMarkets™
AI Revolutionizes Cardiovascular Drug Development with $1.4+ Billion in Strategic Investments

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Healthcare

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.